(3R,4R)-N4-[3-methyl-1-[2-[[1-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)indazol-5-yl]amino]pyrimidin-4-yl]pyrazol-4-yl]tetrahydropyran-3,4-diamine

ID: ALA4740533

PubChem CID: 162644971

Max Phase: Preclinical

Molecular Formula: C24H27N11O2

Molecular Weight: 501.56

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1nnc(-c2nn(C)c3ccc(Nc4nccc(-n5cc(N[C@@H]6CCOC[C@@H]6N)c(C)n5)n4)cc23)o1

Standard InChI:  InChI=1S/C24H27N11O2/c1-13-19(28-18-7-9-36-12-17(18)25)11-35(32-13)21-6-8-26-24(29-21)27-15-4-5-20-16(10-15)22(33-34(20)3)23-31-30-14(2)37-23/h4-6,8,10-11,17-18,28H,7,9,12,25H2,1-3H3,(H,26,27,29)/t17-,18+/m0/s1

Standard InChI Key:  HXUJMGJEVIFQIT-ZWKOTPCHSA-N

Molfile:  

 
     RDKit          2D

 37 42  0  0  0  0  0  0  0  0999 V2000
   21.2249   -7.7014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2238   -8.5250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9359   -8.9381    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.6456   -8.5246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6428   -7.6978    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.9342   -7.2925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3581   -8.9362    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.0693   -8.5223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7784   -8.9344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4891   -8.5212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0631   -7.7031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7708   -7.2917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4844   -7.6999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0960   -7.1513    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.7578   -6.3999    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.9398   -6.4868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8997   -7.3200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9317   -6.4712    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.5919   -5.9848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3370   -5.2042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5157   -5.2067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2656   -5.9888    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.8195   -4.5376    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.4808   -3.7879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9668   -3.1311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6313   -2.3839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8143   -2.2966    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.3338   -2.9588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6662   -3.7123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7835   -3.2182    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.0292   -4.5429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3931   -5.8767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5617   -5.0729    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.8492   -4.6654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2386   -5.2504    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.5764   -5.9633    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.7492   -3.8503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 13  2  0
 12 11  2  0
 11  8  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 12  1  0
 14 17  1  0
  6 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 18  1  0
 20 23  1  0
 24 23  1  6
 24 25  1  0
 24 29  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 25 30  1  6
 21 31  1  0
 32 33  1  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 32  2  0
 16 32  1  0
 34 37  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4740533

    ---

Associated Targets(Human)

SYK Tclin Tyrosine-protein kinase SYK (7372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SUD4 (402 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 501.56Molecular Weight (Monoisotopic): 501.2349AlogP: 2.49#Rotatable Bonds: 6
Polar Surface Area: 159.65Molecular Species: BASEHBA: 13HBD: 3
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.71CX Basic pKa: 9.20CX LogP: 0.58CX LogD: -1.20
Aromatic Rings: 5Heavy Atoms: 37QED Weighted: 0.31Np Likeness Score: -1.45

References

1. Barlaam B,Boiko S,Boyd S,Dry H,Gingipalli L,Ikeda T,Johnson T,Kawatkar S,Lorthioir O,Pike A,Pollard H,Read J,Su Q,Wang H,Wang H,Wang L,Wang P,Edmondson SD.  (2020)  Novel potent and selective pyrazolylpyrimidine-based SYK inhibitors.,  30  (22): [PMID:32877741] [10.1016/j.bmcl.2020.127523]

Source